MKI67 and neuroendocrine carcinoma: In addition, a recent landmark study showed that grade 3 NECs with a Ki67 index less than 55% do not respond to platinum based chemotherapy, in contrast to grade 3 NEC with a Ki67 index greater than 55% [9].